Trials / Recruiting
RecruitingNCT05766384
Hyperpolarized 129Xe MRI Lung Health Cohort
Hyperpolarized 129Xe MRI to Identify Structural Determinants of Low Lung Function and Respiratory Symptoms in Young Adults From the Lung Health Cohort
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 260 (estimated)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 25 Years – 35 Years
- Healthy volunteers
- —
Summary
A subset of young adults participating in the American Lung Association (ALA) Lung Health Cohort (LHC) will be imaged using Hyperpolarized 129Xe MRI to assess lung structure and function. Images will be used to improve the understanding of lung health and early lung abnormalities that may lead to chronic lung disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyperpolarized Xe129 | Inhaled hyperpolarized 129Xe used as a signal agent for MRI of the lungs. |
Timeline
- Start date
- 2023-11-30
- Primary completion
- 2027-03-31
- Completion
- 2027-03-31
- First posted
- 2023-03-13
- Last updated
- 2025-04-02
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05766384. Inclusion in this directory is not an endorsement.